Rani Therapeutics Inc. (RANI)
1.29
0.01 (0.78%)
At close: Jan 15, 2025, 2:31 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Revenue | n/a | n/a | 2.72M | 462.00K | 979.00K |
| Cost of Revenue | 822.00K | 1.31M | n/a | n/a | n/a |
| Gross Profit | -822.00K | -1.31M | 2.72M | 462.00K | 979.00K |
| Operating Income | -66.10M | -63.45M | -51.60M | -16.54M | -27.07M |
| Interest Income | 3.30M | 1.25M | 89.00K | 63.00K | 423.00K |
| Pretax Income | -67.88M | -63.27M | -53.05M | -16.67M | -26.59M |
| Net Income | -33.97M | -63.34M | -53.09M | -16.70M | -26.60M |
| Selling & General & Admin | 26.48M | 26.84M | 27.83M | 4.96M | 3.46M |
| Research & Development | 39.62M | 36.61M | 26.48M | 12.04M | 24.58M |
| Other Expenses | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 66.10M | 63.45M | 54.32M | 17.01M | 28.04M |
| Interest Expense | 5.08M | 1.07M | 466.00K | 124.00K | 10.00K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 66.10M | 63.45M | 54.32M | 17.01M | 28.04M |
| Income Tax | n/a | 70.00K | 41.00K | 35.00K | 10.00K |
| Shares Outstanding (Basic) | 25.50M | 23.82M | 19.71M | 19.74M | 19.74M |
| Shares Outstanding (Diluted) | 25.50M | 23.82M | 19.71M | 19.74M | 19.74M |
| EPS (Basic) | -1.33 | -2.66 | -2.69 | -0.85 | -1.35 |
| EPS (Diluted) | -1.33 | -2.66 | -2.69 | -0.85 | -1.35 |
| EBITDA | -65.28M | -60.89M | -52.08M | -15.96M | -26.01M |
| Depreciation & Amortization | 822.00K | 1.31M | 497.00K | 589.00K | 564.00K |